|
In a landmark move to strengthen India’s governance architecture and accelerate digital transformation in healthcare and pharmaceuticals sectors, the Capacity Building Commission (CBC) formalised a strategic partnership with the Research and Information System for Developing Countries (RIS) during Strengthening Adaptive Development and Humane Aptitude for National Advancement (Sadhana) Saptah 2026.
Sadhana Saptah 2026 is being organised from April 2 to 8, 2026 as one of the largest collaborative capacity building initiatives in India, that aims to foster skills necessary for citizen centric governance.
The partnership is anchored in CBC’s broader vision of the Global Digital Capacity Building Alliance, which is an initiative designed to reimagine governance through artificial intelligence, digital infrastructure, and global collaboration. By combining RIS’s research depth and international policy networks with CBC’s institutional mandate, the collaboration seeks to create a scalable digital capacity-building ecosystem capable of transforming how governments operate and deliver services.
The Memorandum of Understanding (MoU) was signed in the presence of Jitendra Singh, minister of state for personnel, public grievances and pensions, marking a decisive step toward building AI-enabled, future-ready public healthcare institutions. Senior leadership from both institutions, including S. Radha Chauhan, chairperson, CBC, and Professor Sachin Kumar Sharma, director general (DG), RIS, were present at the signing, along with key policymakers and experts.
Among them, Anil Jauhri, former CEO of National Accreditation Board for Certification Bodies (NABCB) and Visiting Fellow at RIS, highlighted the importance of the initiative, noting that “through this initiative, the government will train its officers on standards related to the ecosystem, which is a welcome step.” His remarks underscore a crucial dimension of the partnership, embedding standards, quality frameworks, and global best practices into the training of public officials.
While the MoU is positioned within administrative reforms, its implications for healthcare and the pharmaceutical sector are both immediate and far-reaching. Modern healthcare systems depend heavily on efficient governance, data interoperability, and skilled human capital, all of which are central to this partnership.
By fostering AI-native public officials, the initiative aims to equip decision-makers with the tools to manage complex health ecosystems. This includes the use of predictive analytics for disease surveillance, AI-assisted policy planning, and real-time monitoring of public health interventions. Such capabilities are essential in a world where health crises, from pandemics to antimicrobial resistance, require rapid, coordinated, and data-driven responses.
A key pillar of the CBC–RIS collaboration is the development of a robust digital capacity-building framework that extends to the healthcare workforce. This includes training administrators and health officials in AI and data governance, creating scalable platforms for continuous learning and skill development, enabling frontline healthcare workers with decision-support tools powered by AI.
By institutionalising these capabilities, the partnership ensures that healthcare systems are not only technologically advanced but also supported by a workforce capable of leveraging these tools effectively.
The pharmaceutical industry stands to benefit significantly from the governance reforms enabled by this partnership. AI-driven regulatory systems can streamline approval processes, reduce delays in clinical trials, and enhance transparency. Additionally, standardized frameworks.
Anil Jauhri emphasized that this initiative can facilitate harmonised quality and compliance standards, faster cross-border collaboration in drug development and improved pharmacovigilance through real-time data integration. These changes can position India as a global leader in AI-powered pharmaceutical innovation, while ensuring safety and efficacy remain uncompromised.
According to experts, the CBC–RIS partnership also reflects a broader shift toward new models of international cooperation. By leveraging RIS’s global engagement and policy expertise, the initiative aims to create platforms for cross-country knowledge exchange on digital governance and healthcare innovation, development of shared AI standards and ethical frameworks.
Experts further added that such efforts are critical in addressing global health challenges that transcend national boundaries, from pandemic preparedness to equitable access to medicines. The integration of AI into governance processes enables real-time decision-making, reduces administrative inefficiencies, and enhances service delivery. For healthcare, this translates into better patient outcomes, optimized resource allocation, and stronger system resilience. For the pharmaceutical sector, it means a more enabling environment for innovation, supported by robust regulatory and quality frameworks.
|